News

• Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia
  05/16/2019 / 07:03 - GlobeNewswire
•  
• Roche's personalised medicine entrectinib shrank tumours harbouring NTRK, ROS1 or ALK gene fusions in children and adolescents
  05/16/2019 / 07:00 - GlobeNewswire
•  
• New Roche test aids clinicians in accelerating tuberculosis diagnosis and treatment by detecting antimicrobial resistance within the world's leading cause of infectious disease deaths
  05/14/2019 / 07:03 - GlobeNewswire
•  
• Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Report Forms under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.
  05/14/2019 / 07:00 - GlobeNewswire
•  
• Roche to present new data highlighting comprehensive approach to cancer care at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
  05/10/2019 / 07:00 - GlobeNewswire
•  
• Roche to present new OCREVUS (ocrelizumab) data analyses showing significant reduction of disability progression in relapsing and primary progressive multiple sclerosis at the AAN Annual Meeting
  05/08/2019 / 07:00 - GlobeNewswire
•  
• Roche presents data from the risdiplam pivotal FIREFISH and SUNFISH studies in spinal muscular atrophy at the 2019 AAN Annual Meeting
  05/07/2019 / 07:00 - GlobeNewswire
•  
• FDA approves Roche's Kadcyla for adjuvant treatment of people with HER2-positive early breast cancer with residual invasive disease after neoadjuvant treatment
  05/06/2019 / 07:00 - GlobeNewswire
•  
• New Roche data at the 2019 AAN Annual Meeting showcase breadth and promise of neuroscience portfolio
  04/29/2019 / 07:00 - GlobeNewswire
•  
• Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.
  04/26/2019 / 07:00 - GlobeNewswire
•  
• Roche launches new VENTANA HER2 Dual ISH companion diagnostic test for breast and gastric cancer patients eligible for targeted therapy
  04/23/2019 / 07:00 - GlobeNewswire
•  
• Roche reports a strong start in 2019 and raises the outlook for the full-year
  04/17/2019 / 07:00 - GlobeNewswire
•  
• Roche extends Spark Therapeutics offer to May 2
  04/03/2019 / 09:45 - TeleTrader
•  
• Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.
  04/03/2019 / 07:00 - GlobeNewswire
•  
• Roche's ipatasertib in combination with Tecentriq and chemotherapy shows promising anti-tumour activity in triple-negative breast cancer in early phase trial
  04/01/2019 / 07:00 - GlobeNewswire